Back
First Trust Short Duration Managed Municipal ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
22
FSMB
First Trust Short Duration Managed Municipal ETF
Last Price:
$19.99
Seasonality Move:
-0.98%
Sell
17
NONOF
Novo Nordisk A/S
Last Price:
$35.59
Seasonality Move:
4.8%
Sell
22
First Trust Short Duration Managed Municipal ETF (FSMB)
is a Sell
Is First Trust Short Duration Managed Municipal ETF a Buy, Sell or Hold?
-
The current First Trust Short Duration Managed Municipal ETF [FSMB] share price is $19.99. The Score for FSMB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
FSMB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
FSMB Stock Price Chart
What is First Trust Short Duration Managed Municipal ETF's stock price today?
-
The First Trust Short Duration Managed Municipal ETF share price today is $19.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FSMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $35.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
FSMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.44 | Buy |
| Relative Strength Index (14 RSI): | 37.83 | Sell |
| Chaikin Money Flow: | 46871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.98 - 20.16) | Sell |
| Bollinger Bands (100): | (20.01 - 20.17) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.13 | Sell |
| Relative Strength Index (14 RSI): | 34 | Sell |
| Chaikin Money Flow: | -84014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.94 - 38.44) | Sell |
| Bollinger Bands (100): | (39.64 - 55.38) | Sell |
FSMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.96 | Buy |
| 20-day SMA: | 20.05 | Sell |
| 50-day SMA: | 20.12 | Sell |
| 200-day SMA: | 20.05 | Sell |
| 8-day EMA: | 19.62 | Buy |
| 20-day EMA: | 15.97 | Buy |
| 50-day EMA: | 9.46 | Buy |
| 200-day EMA: | 2.96 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.83 | Sell |
| 20-day SMA: | 37 | Sell |
| 50-day SMA: | 44.15 | Sell |
| 200-day SMA: | 53.01 | Sell |
| 8-day EMA: | 35.83 | Sell |
| 20-day EMA: | 37.34 | Sell |
| 50-day EMA: | 41.96 | Sell |
| 200-day EMA: | 54.32 | Sell |
First Trust Short Duration Managed Municipal ETF Earnings Growth & FSMB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Short Duration Managed Municipal ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||